Global Cardiovascular Information System Market 2021 (Includes Business Impact of COVID-19)

                                          
Report updated on 11th September, 2021: Global Cardiovascular Information System Market 2021 (Includes Business Impact of COVID-19)
Global Cardiovascular Information System Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2030 is a recent report generated by Trusted Business Insights. The global Cardiovascular Information System market report has been segmented on the basis of component, deployment, application, end user, and region.
Request Covid - 19 Impact
The global Cardiovascular Information System market size was valued at USD $902.97 million in 2020 and is projected to reach $1906.67 million by 2030, and is anticipated to expand at a CAGR of 7.75% over the forecast period from 2020 to 2030.


Global Cardiovascular Information System Market: Overview


Cardiovascular information system is a management platform allows easily report generation and distribution process for cardiologist and clinical staffs. Cardiovascular information system in hospitals helps to eliminate duplicate entries and reduce human errors.


Global Cardiovascular Information System Market: Dynamics


Increasing technological advancements for database modules within CVIS includes entire spectrum of cardiovascular activities -both invasive and non-invasive is a key factor expected to drive growth of the global market over the forecast period.

In addition, rising imaging and diagnostic tests across various countries globally is expected to further fuel growth of the target market over the forecast period.

Moreover, increasing acquisition, collaboration, and strategic partnership agreement activities   among manufacturers operating in the global market is expected to boost growth of the target market over the forecast period. For instance, in June 2016, McKesson Corporation -a leading healthcare services and information technology provider along with Change Healthcare Holdings, Inc.-which is a US-based software and analytics, network solutions, and technology-enabled services provide are launched a new healthcare information technology company -Change Healthcare. Moreover, in April 2017, Siemens Healthineers entered in to partnership with Ebit in order to offer Ebits Suitestensa cardiovascular information system (CVIS) with Siemens cardiology systems across Germany.

However, high cost of cardiovascular information system and lack of technical standards for implementation of CVIS solution across developing economies are major factors expected to restrain growth of the target market over the forecast period.

Rising various healthcare organizations preference towards cloud-based solutions for cardiovascular information system is expected to create lucrative opportunities for players operating in the target market over the forecast period.


Global Cardiovascular Information System Market: Segment Analysis


By component, the service component segment is expected to register highest CAGR over the forecast period, owing to rising need to integrate CVIS with CPACS/EMR and other cardiology modules.

By delivery mode, the cloud-based delivery mode segment is expected to register significant growth in terms of revenue over the forecast period.

By end user segment, the hospitals segment is expected to register highest share in terms of revenue over the forecast period, owing to rising adoption of CVIS solutions in large number of hospitals across various countries globally.


Global Cardiovascular Information System Market: Regional Analysis


The market in North America is expected to dominate in the global market and is expected to continue its dominance over the forecast period, owing to increasing incidence of cardiovascular diseases and rising adoption of technologically advanced products. In addition, availability of advanced healthcare facilities and better reimbursement policies across various countries in this region is expected to support growth of the target market in North America. The market in Asia Pacific is expected to register significant growth rate in terms of CAGR in the global market, owing to increasing demand for cardiologists in order to produce a report from cardiology picture archiving and communication systems (CPACS) by viewing cardiac images and integration of reports. Moreover, increasing demand for generating enterprise information management solution and reduce healthcare cost are some other factors expected to support growth of the target market in this region.


Below are the active patents related to Cardiovascular Information System Market.


Patent Number: US20140148693A1

Method and system for patient-specific modeling of blood flow

Abstract

Embodiments include a system for determining cardiovascular information for a patient. The system may include at least one computer system configured to receive patient-specific data regarding a geometry of the patients heart, and create a three-dimensional model representing at least a portion of the patients heart based on the patient-specific data. The at least one computer system may be further configured to create a physics-based model relating to a blood flow characteristic of the patients heart and determine a fractional flow reserve within the patients heart based on the three-dimensional model and the physics-based model.

Application filed Date: 2013-11-15

Application granted Date: 2020-06-16

Current Assignee: HeartFlow Inc

Global Cardiovascular Information System Market Segmentation:

Segmentation by component:

  
Software
  
Services

Segmentation by deployment:

  
Cloud-Based
  
On-Premise

Segmentation by application:

  
Cardiac and Peripheral Catheterization
  
Hemodynamics Monitoring
  
Electrophysiology
  
Echocardiography
  
Others (Nuclear Cardiology, Ecg/Holter Monitoring, Heart Failure Center, etc.)

Segmentation by end user:

  
Hospitals
  
Diagnostic Laboratories
  
Ambulatory Surgical Centers
  
Clinics (Cardiac Cath Labs, clinics, etc.)


Key Market Players included in the report:


  
Agfa Healthcare (Belgium)
  
Cerner Corporation.
  
Digisonics Inc
  
Fujifilm Holdings Corporation
  
GE Healthcare (U.K)
  
General Electric Company
  
IBM (Merge Healthcare)
  
Koninklijke Philips N.V.
  
Lumedx (U.S.)
  
McKesson Corporation (U.S.)
  
Merge Healthcare (U.S.)
  
Philips Healthcare (Netherlands)
  
Siemens Healthcare


Below are the key development related to Cardiovascular Information System Market in 2020 and 2021.


March 2021: Cardiovascular Systems, Inc. Announces Acquisition of Peripheral Support Catheters From WavePoint Medical, LLC. Agreement also includes development of portfolio of CTO products.Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) announced that it has acquired a line of peripheral support catheters from WavePoint Medical, LLC. Peripheral support catheters are used during peripheral vascular intervention (PVI) procedures for guidewire support to enable lesion crossing, as well as for guidewire exchanges. Physicians use support catheters in approximately 50% of PVIs, primarily in below-the-knee and complex interventions. When calcium is present, lesions can be challenging to cross with an interventional guidewire and often require advanced tools prior to vessel preparation and treatment. CSI anticipates it will introduce the acquired catheters as its new ViperCross™ line in the first half of its fiscal year ending June 30, 2022. Source

February 2021: Leading Imaging Software Company Intelerad Medical Systems Announces Acquisition of LUMEDX. Acquisition marks Intelerad’s third in six months, expanding the organization’s ability to provide enterprise imaging and insights and deepening its cardiovascular expertise and analytics capabilities. Source

October 2020: GE Healthcare announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid1 cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently. Methodical assessments of heart function are key in echocardiography but can be tedious and time-consuming to acquire. High quality data acquisition and operator skill are key elements to achieve accurate and complete exams. And, as patients undergo subsequent monitoring exams, the reproducibility of exam assessments is key to identifying improvement or disease progression. Vivid Ultra Edition brings increased efficiencies to the scanning process for reduced exam time through up to 80% fewer clicks. Source